Shots in the Dark: How Can Clinicians Bridge the Immunization Gaps Widened by the COVID-19 Pandemic?

Premiere Date: March 4, 2022

This activity offers credit for:

1. Physicians (CME)
2. Nurses (ANCC)

Credit expiration date: March 3, 2023

	Laura D. Lipold, MD Director, Primary Care Women’s Health Section Head, Family Medicine Beachwood Family Health Center Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Assistant Professor of Family Medicine Department of Family Medicine Cleveland Clinic Cleveland, OH
	Susan J. Rehm, MD Department of Infectious Disease Cleveland Clinic Cleveland, OH
	Amy M. Zack, MD, FAAFP Family Medicine Physician Southpointe Medical Center Vice-Chair of Education Cleveland Clinic Community Care Cleveland, OH

Program Description

How can we bridge current immunization gaps further widened by the COVID-19 pandemic? Leading HPV and pneumococcal vaccine experts come together in this roundtable discussion to share their experiences and strategies to increase vaccination rates. Additionally, faculty discuss the safety and efficacy data with the latest HPV and pneumococcal vaccine approvals.

Activity Purpose

Clinicians (primary care clinicians, advanced practice providers, nurses) involved in ensuring optimal vaccination of HPV and pneumococcal disease need to become more aware of the impact of the COVID-19 pandemic on adolescent and adult immunization rates. These clinicians need to also better understand the current provider-led strategies to improve HPV and pneumococcal vaccination. Finally, these clinicians must also understand the clinical evidence with the latest HPV and pneumococcal approvals and how to incorporate newer HPV and pneumococcal vaccines into appropriate immunization plans.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Discuss the impact of the COVID-19 pandemic on adolescent and adult immunization rates
• Implement clinician-led strategies to facilitate uptake of HPV and pneumococcal vaccines post-pandemic
• Evaluate the latest safety and efficacy data with the latest pneumococcal conjugate and HPV vaccine approvals
• Incorporate newer pneumococcal conjugate and HPV vaccines into appropriate adult immunization plans as recommended

Sponsorship

Sponsored by the Academy for Continued Healthcare Learning (ACHL) and Cleveland Clinic Center for Continuing Education.

Financial Support

Supported by an educational grant from Merck & Co., Inc.

Target Audience

This activity is intended for primary care physicians, advanced practice providers, nurses, and other clinicians involved in immunization of adolescents and adults.

ACCREDITATION

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION

• American Medical Association (AMA) Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits^™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• American Nurses Credentialing Center (ANCC) Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 1.0 ANCC contact hours.

• Certificate of Participation A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

There is no fee to participate in this activity nor to generate certificates.

Learning Formats

This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Katie Hacias at khacias@achlcme.org

Disclosure Declaration

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following financial relationships have been provided:
Susan Rehm, MD
Advisor or review panel participant: Pfizer
Teaching and Speaking: Merck
Ownership interest (stock, stock options in a publicly owned company): Amgen; Eli Lilly; Medtronic; Merck; Pfizer; Roche

The following faculty have indicated they have nothing to disclose:

Laura Lipold, MD
Amy Zack, MD, FAAFP

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Cleveland Clinic Center for Continuing Education and ACHL staff involved with the planning, development, and review of this activity have no relevant affiliations or financial relationships to disclose.

Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.  The viewpoints expressed in this CME activity are those of the authors/faculty.  They do not represent an endorsement by The Cleveland Clinic Foundation.  In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. CCF requires the speaker to disclose that a product is not labeled for the use under discussion.